VCF formatted files are the lingua franca of next-generation sequencing, whereas HL7 FHIR is rising as a commonplace language for digital well being document interoperability. A rising variety of FHIR-based scientific genomics functions are rising. Here, we describe an open supply utility for changing variants from VCF format into HL7 FHIR format. vcf2fhir converts VCF variants into a FHIR Genomics Diagnostic Report. Conversion interprets every VCF row into a corresponding FHIR-formatted variant within the generated report. In scope are easy variants (SNVs, MNVs, Indels), together with zygosity and section relationships, for autosomes, intercourse chromosomes, and mitochondrial DNA. Input parameters embody VCF file and genome construct (‘GRCh37’ or ‘GRCh38’); and optionally a conversion area that signifies the area(s) to convert, a studied area that lists genomic areas studied by the lab, and a non-callable area that lists studied areas deemed uncallable by the lab.
Conversion may be restricted to a subset of VCF by supplying genomic coordinates of the conversion area(s). If studied and non-callable areas are additionally provided, the output FHIR report will embody ‘region-studied’ observations that element which parts of the conversion area have been studied, and of these studied areas, which parts have been deemed uncallable. We illustrate the vcf2fhir utility by way of two case research. The first, ‘SMART Cancer Navigator’, is a net utility that provides scientific resolution assist by linking affected person EHR data to cancerous gene variants.
The second, ‘Precision Genomics Integration Platform’, intersects a affected person’s FHIR-formatted scientific and genomic information with information bases so as to present on-demand supply of contextually related genomic findings and proposals to the EHR. Experience to date exhibits that the vcf2fhir utility may be successfully woven into clinically helpful genomic-EHR integration pipelines. Additional testing can be a crucial step in the direction of the scientific validation of this utility, enabling it to be built-in in a number of actual world information movement situations. For now, we suggest using this utility primarily to speed up FHIR Genomics understanding and to facilitate experimentation with additional integration of genomics information into the EHR.
Implementation of Bio-Risk Management System in a National Clinical and Medical Referral Centre Laboratories
The rising threats from organic brokers have turn into a concern in laboratories, and rising infectious ailments have demanded elevated consciousness and preparedness of laboratory amenities. Bio-risk evaluation is required to present a framework for organisations to set up a complete bio-risk administration system. The evaluation standards ought to embody each biosafety and biosecurity measures. Laboratories in Indonesia play a important function in public well being interventions in time period of illness screening, analysis and medical resolution making. The National Clinical and Medical Referral Centre Laboratories have the potential of day by day exposures to harmful organic supplies.
This research goals to establish the hole between bio-risk administration system implementation and International Standard Organisation (ISO) 35001:2019 necessities. The 202 gadgets in ISO 35001:2019 are categorized into seven predominant components. The findings present that greater than half of the weather on ISO 35001:2019 have been applied in these centres. Good efficiency was recognized at lab Four and 5 which obtained the very best scores, notably within the context of organisation, planning, operation and enchancment components. However, the widest hole was present in management, assist and efficiency analysis. One means to deal with this could be to create written guidelines and laws on the laboratory high administration degree to require all laboratory amenities to comply to the bio-risk insurance policies, guidelines, and laws.
Out of the Lab and Into the Field: Validation of Portable Cell Culture Protocols
Field-based analysis on irritation and well being is usually restricted to baseline measures of circulating cytokines or acute section proteins, whereas lab-based research can pursue a extra dynamic strategy with ex vivo cell tradition strategies. The laboratory infrastructure required for culturing leukocytes limits utility in community-based settings, which in flip limits scientific understandings of how psychosocial, behavioral, and contextual components affect the regulation of irritation. We evaluated the efficiency of each protocols towards a commonplace laboratory-based protocol, utilizing matched venous and capillary blood samples collected from younger adults (N=24). Samples have been incubated with lipopolysaccharide (LPS) and hydrocortisone, and the manufacturing of pro-inflammatory cytokines IL-1β, IL-6 and TNFα was measured in response.
 Mouse LIF |
|
MBS692107-5x001mg |
MyBiosource |
5x0.01mg |
EUR 1080 |
 Mouse LIF |
|
300-365P-100ug |
GeminiBio |
100 µg |
Ask for price |
Mouse LIF |
|
300-365P-1mg |
GeminiBio |
1 mg |
Ask for price |
Mouse LIF |
|
300-365P-20ug |
GeminiBio |
20 µg |
Ask for price |
Mouse LIF |
|
300-365P-500ug |
GeminiBio |
500 µg |
Ask for price |
Mouse LIF |
|
300-365P-5ug |
GeminiBio |
5 µg |
Ask for price |
 LIF，Mouse |
|
E34M066M |
EnoGene |
5 μg |
EUR 155 |
 LIF, mouse |
|
MO16102 |
Neuromics |
100 ug |
EUR 494.1 |
 LIF, Mouse |
|
MBS8575391-0005mg |
MyBiosource |
0.005mg |
EUR 245 |
LIF, Mouse |
|
MBS8575391-5x0005mg |
MyBiosource |
5x0.005mg |
EUR 940 |
 Mouse Anti-Human LIF Monoclonal Antibody |
|
MBS592457-01mg |
MyBiosource |
0.1mg |
EUR 365 |
Mouse Anti-Human LIF Monoclonal Antibody |
|
MBS592457-05mg |
MyBiosource |
0.5mg |
EUR 530 |
Mouse Anti-Human LIF Monoclonal Antibody |
|
MBS592457-5x05mg |
MyBiosource |
5x0.5mg |
EUR 2140 |
Mouse Anti-Human LIF Monoclonal Antibody |
|
MBS592458-01mg |
MyBiosource |
0.1mg |
EUR 365 |
Mouse Anti-Human LIF Monoclonal Antibody |
|
MBS592458-05mg |
MyBiosource |
0.5mg |
EUR 530 |
Mouse Anti-Human LIF Monoclonal Antibody |
|
MBS592458-5x05mg |
MyBiosource |
5x0.5mg |
EUR 2140 |
Mouse Anti-Human LIF Monoclonal Antibody |
|
MBS592459-01mg |
MyBiosource |
0.1mg |
EUR 365 |
Mouse Anti-Human LIF Monoclonal Antibody |
|
MBS592459-05mg |
MyBiosource |
0.5mg |
EUR 530 |
Mouse Anti-Human LIF Monoclonal Antibody |
|
MBS592459-5x05mg |
MyBiosource |
5x0.5mg |
EUR 2140 |
) Mouse LIF (AF) |
|
300-838P-100ug |
GeminiBio |
100 µg |
Ask for price |
Mouse LIF (AF) |
|
300-838P-1mg |
GeminiBio |
1 mg |
Ask for price |
Mouse LIF (AF) |
|
300-838P-20ug |
GeminiBio |
20 µg |
Ask for price |
Mouse LIF (AF) |
|
300-838P-500ug |
GeminiBio |
500 µg |
Ask for price |
Mouse LIF (AF) |
|
300-838P-5ug |
GeminiBio |
5 µg |
Ask for price |
 Mouse LIF siRNA |
|
20-abx922546 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
 Mouse LIF Protein |
|
E2PD201245 |
EnoGene |
20ug |
EUR 595 |
Mouse LIF Protein |
|
E40MOP1672 |
EnoGene |
20ug |
EUR 495 |
Mouse LIF Protein |
|
E40MOP2026 |
EnoGene |
20ug |
EUR 495 |
Mouse LIF Protein |
|
E40MOP2028 |
EnoGene |
20ug |
EUR 495 |
 LIF, Mouse, Monoclonal Antibody, Mouse |
|
MBS555093-01mg |
MyBiosource |
0.1mg |
EUR 745 |
LIF, Mouse, Monoclonal Antibody, Mouse |
|
MBS555093-5x01mg |
MyBiosource |
5x0.1mg |
EUR 3210 |
) LIF siRNA (Mouse) |
|
MBS8224619-15nmol |
MyBiosource |
15nmol |
EUR 405 |
LIF siRNA (Mouse) |
|
MBS8224619-30nmol |
MyBiosource |
30nmol |
EUR 565 |
LIF siRNA (Mouse) |
|
MBS8224619-5x30nmol |
MyBiosource |
5x30nmol |
EUR 2450 |
 Recombinant Mouse LIF |
|
MBS4159936-001mg |
MyBiosource |
0.01mg |
EUR 230 |
Recombinant Mouse LIF |
|
MBS4159936-01mg |
MyBiosource |
0.1mg |
EUR 560 |
Recombinant Mouse LIF |
|
MBS4159936-1mg |
MyBiosource |
1mg |
EUR 1500 |
Recombinant Mouse LIF |
|
MBS4159936-5x1mg |
MyBiosource |
5x1mg |
EUR 6500 |
Recombinant Mouse LIF |
|
MBS7609292-005mg |
MyBiosource |
0.05mg |
EUR 405 |
Recombinant Mouse LIF |
|
MBS7609292-02mg |
MyBiosource |
0.2mg |
EUR 760 |
Recombinant Mouse LIF |
|
MBS7609292-1mg |
MyBiosource |
1mg |
EUR 2175 |
Recombinant Mouse LIF |
|
MBS7609292-5x1mg |
MyBiosource |
5x1mg |
EUR 8410 |
Recombinant Mouse LIF |
|
P1174-.005 |
ApexBio |
5ug |
EUR 108.8 |
|
Description: Peptides & Proteins|Recombinant Proteins |
Recombinant Mouse LIF |
|
P1174-.1 |
ApexBio |
100ug |
EUR 840.8 |
|
Description: Peptides & Proteins|Recombinant Proteins |
Recombinant Mouse LIF |
|
P1174-.5 |
ApexBio |
500ug |
EUR 1885.6 |
|
Description: Peptides & Proteins|Recombinant Proteins |
Recombinant Mouse LIF |
|
Z200195 |
ABM |
10 µg |
EUR 85 |
|
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix-bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation. It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1. The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |
Recombinant Mouse LIF |
|
Z200197 |
ABM |
100 µg |
EUR 385 |
|
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix-bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation. It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1. The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |
Recombinant Mouse LIF |
|
Z200199 |
ABM |
1.0 mg |
EUR 1200 |
|
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix-bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation (2). It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1 (2). The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |
Recombinant Mouse LIF |
|
Z200485 |
ABM |
100 µg |
EUR 1500 |
|
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix-bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation (2). It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1 (2). The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |
 LIF Protein, Mouse |
|
UA040061 |
Starter Biotechnology Co Ltd |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 5 µg
- 10 µg
- 50 µg
- 100 µg
- 500 µg
- 1 mg
|
 Anti-Mouse LIF Antibody |
|
103-M263 |
ReliaTech |
100 µg |
EUR 399 |
|
Description: Based on its helical structure, LIF (Leukemia Inhibitory Factor) is considered a member of the Interleukin-6 family of cytokines. Functionally, it has been implicated in a many physiological processes including development, hematopoiesis, bone metabolism, and inflammation. Some cell types known to express LIF include activated T cells, monocytes, astrocytes, osteoblasts, keratinocytes, regenerating skeletal muscle, mast cells, and fibroblasts. |
Anti-Mouse LIF Antibody |
|
103-PA05S |
ReliaTech |
100 µg |
EUR 126 |
|
Description: Leukemia Inhibitory Factor also called LIF is a lymphoid factor that promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Leukemia Inhibitory Factor has several functions such as cholinergic neuron differentiation, control of stem cell pluripotency, bone & fat metabolism, mitogenesis of factor dependent cell lines & promotion of megakaryocyte production in vivo. Human and mouse LIF exhibit a 78% identity in its amino acid sequence. Human LIF is as active on human cells as is it is on mouse cells, though mouse LIF is about 1000 fold less active on human cells, than human LIF. |
, (recombinant)) LIF (mouse), (recombinant) |
|
MBS566073-1mL |
MyBiosource |
1mL |
EUR 1470 |
LIF (mouse), (recombinant) |
|
MBS566073-5x1mL |
MyBiosource |
5x1mL |
EUR 6555 |
 LIF, Mouse Recombinant |
|
L4500 |
GenDepot |
1 MIU/mL |
Ask for price |
 Mouse LIF ELISA Kit |
|
E28L0650 |
EnoGene |
96T |
EUR 666.67 |
Mouse LIF ELISA Kit |
|
EK5250 |
SAB |
96 tests |
EUR 599 |
|
|
Mouse LIF ELISA Kit |
|
EML0014 |
Abclonal |
96Tests |
EUR 625.2 |
 Mouse LIF shRNA Plasmid |
|
20-abx971321 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
 Mouse Recombinant Protein) Lif (NM_008501) Mouse Recombinant Protein |
|
E45M43185M5 |
EnoGene |
20 ug |
EUR 1924.54 |
Lif (NM_008501) Mouse Recombinant Protein |
|
E45M42302E0 |
EnoGene |
20 ug |
EUR 1088.75 |
 LIF, Human, Monoclonal Antibody, Mouse |
|
MBS555094-01mg |
MyBiosource |
0.1mg |
EUR 745 |
LIF, Human, Monoclonal Antibody, Mouse |
|
MBS555094-5x01mg |
MyBiosource |
5x0.1mg |
EUR 3210 |
 Recombinant Mouse LIF protein |
|
CD00323-5ug |
Jiaxing Korain Biotech Ltd (BT Labs) |
5ug |
EUR 176 |
|
|
|
Description: Leukemia inhibitory factor (LIF) is a member of Interleukin 6 family. This protein is mainly expressed in the trophectoderm of the developing embryo, with its receptor LIFR expressed throughout the inner cell mass. LIF has the capacity to induce terminal differentiation in leukemic cells. Its activities include the induction of hematopoietic differentiation in normal and myeloid leukemia cells, the induction of neuronal cell differentiation, and the stimulation of acute-phase protein synthesis in hepatocytes. LIF is used in mouse embryonic stem cell culture, because that removal of LIF pushes stem cells toward differentiation, but they retain their proliferative potential or pluripotency. It is also used in phase II clinical trial, which can assist embryo implantation in women who have failed to become pregnant despite assisted reproductive technologies (ART). Mature mouse LIF shares 78 % a.a. sequence identity with Human LIF. |
Recombinant Mouse LIF protein |
|
IMP-1308 |
Creative BioMart |
10µg |
EUR 360 |
|
|
|
Description: Recombinant Proteins |
 Mouse LIF Recombinant Protein |
|
M30-007 |
ReliaTech |
10 µg |
EUR 99.75 |
|
Description: Leukemia Inhibitory Factor also called LIF is a lymphoid factor that promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Leukemia Inhibitory Factor has several functions such as cholinergic neuron differentiation, control of stem cell pluripotency, bone & fat metabolism, mitogenesis of factor dependent cell lines & promotion of megakaryocyte production in vivo. Human and mouse LIF exhibit a 78% identity in its amino acid sequence. Human LIF is as active on human cells as is it is on mouse cells, though mouse LIF is about 1000 fold less active on human cells, than human LIF. Recombinant mouse LIF produced in E. coli is a single, non-glycosylated, polypeptide chain containing 180 amino acids and having a molecular mass of 19.86 kDa. |
Mouse LIF Recombinant Protein |
|
M30-008 |
ReliaTech |
50 µg |
EUR 246.75 |
|
Description: Leukemia Inhibitory Factor also called LIF is a lymphoid factor that promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Leukemia Inhibitory Factor has several functions such as cholinergic neuron differentiation, control of stem cell pluripotency, bone & fat metabolism, mitogenesis of factor dependent cell lines & promotion of megakaryocyte production in vivo. Human and mouse LIF exhibit a 78% identity in its amino acid sequence. Human LIF is as active on human cells as is it is on mouse cells, though mouse LIF is about 1000 fold less active on human cells, than human LIF. Recombinant mouse LIF produced in E. coli is a single, non-glycosylated, polypeptide chain containing 180 amino acids and having a molecular mass of 19.86 kDa. |
 Recombinant Mouse LIF Protein |
|
MBS1751002-01mg |
MyBiosource |
0.1mg |
EUR 315 |
Recombinant Mouse LIF Protein |
|
MBS1751002-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1270 |
Recombinant Mouse LIF Protein |
|
MBS8249390-001mg |
MyBiosource |
0.01mg |
EUR 230 |
Recombinant Mouse LIF Protein |
|
MBS8249390-005mg |
MyBiosource |
0.05mg |
EUR 480 |
Recombinant Mouse LIF Protein |
|
MBS8249390-05mg |
MyBiosource |
0.5mg |
EUR 2825 |
Recombinant Mouse LIF Protein |
|
MBS8249390-5x05mg |
MyBiosource |
5x0.5mg |
EUR 12640 |
Recombinant Mouse LIF Protein |
|
PKSM041100-100ug |
Elabscience Biotech |
100ug |
EUR 739 |
|
|
|
Description: Mouse |
Recombinant Mouse LIF Protein |
|
PKSM041100-20ug |
Elabscience Biotech |
20ug |
EUR 249 |
|
|
|
Description: Mouse |
Recombinant Mouse LIF Protein |
|
R01400-1 |
BosterBio |
100ug/vial |
EUR 240 |
|
|
|
Description: SPLPI TPVNA TCAIR HPCHG NLMNQ IKNQL AQLNG SANAL FISYY TAQGE PFPNN VEKLC APNMT DFPSF HGNGT EKTKL VELYR MVAYL SASLT NITRD QKVLN PTAVS LQVKL NATID VMRGL LSNVL CRLCN KYRVG HVDVP PVPDH SDKEA FQRKK LGCQL LGTYK QVISV VVQAF |
Recombinant Mouse LIF Protein |
|
PM0130M2 |
Leading Biology |
20 µg |
Ask for price |
|
Description: Leukemia inhibitory factor, or LIF, is an interleukin 6 class cytokine that affects cell growth by inhibiting differentiation. When LIF levels drop, the cells differentiate.LIF derives its name from its ability to induce the terminal differentiation of myeloid leukemic cells, thus preventing their continued growth. Other properties attributed to the cytokine include: the growth promotion and cell differentiation of different types of target cells, influence on bone metabolism, cachexia, neural development, embryogenesis and inflammation. p53 regulated LIF has been shown to facilitate implantation in the mouse model and possibly in humans. It has been suggested that recombinant human LIF might help to improve the implantation rate in women with unexplained infertility. |
 LIF Protein, Mouse, Recombinant |
|
E45M52739M0-20-ug |
EnoGene |
20 ug |
EUR 291.15 |
LIF Protein, Mouse, Recombinant |
|
PM52739M0 |
Leading Biology |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
 Anti-LIF Antibody, Mouse Monoclonal |
|
MBS8107490-01mL |
MyBiosource |
0.1mL |
EUR 300 |
Anti-LIF Antibody, Mouse Monoclonal |
|
MBS8107490-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1200 |
 Mouse LIF, C-His Tag |
|
HA210735 |
HUABIO |
100 µg |
Ask for price |
 anti- LIF antibody |
|
FNab09804 |
FN Test |
100µg |
EUR 658.5 |
|
|
|
Description: Antibody raised against LIF |
 Mouse LIF PicoKine ELISA Kit |
|
MBS178717-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 2755 |
Mouse LIF PicoKine ELISA Kit |
|
MBS178717-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 600 |
 Recombinant Mouse LIF, Tag Free |
|
PM2019-.01 |
ApexBio |
10ug |
EUR 208 |
|
Description: Peptides & Proteins|Recombinant Proteins |
Recombinant Mouse LIF, Tag Free |
|
PM2019-.1 |
ApexBio |
10X10ug |
EUR 784 |
|
Description: Peptides & Proteins|Recombinant Proteins |
 (pORF)) Lif ORF Vector (Mouse) (pORF) |
|
ORF049145 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Lif ORF Vector (Mouse) (pORF) |
|
ORF049146 |
ABM |
1.0 ug DNA |
EUR 607.2 |
 LIF, Mouse Recombinant , 1MIU/ml |
|
L4500-001 |
GenDepot |
1ml |
EUR 235 |
LIF, Mouse Recombinant , 1MIU/ml |
|
L4500-005 |
GenDepot |
5x1ml |
EUR 890 |
 (OKBB00760)) LIF ELISA Kit (Mouse) (OKBB00760) |
|
OKBB00760 |
Aviva Systems Biology |
96 Wells |
EUR 606 |
|
Description: Description of target: Leukemia inhibitory factor, or LIF, is an interleukin 6 class cytokine that affects cell growth by inhibiting differentiation. When LIF levels drop, the cells differentiate. The LIF was mapped gene to 22q11-q12.2 by Southern analysis of a series of mouse/human somatic cell hybrids and by in situ hybridization to the chromosomes of 2 normal males and some individuals with chromosomal rearrangements. The gene maps between the Philadelphia translocation BCR1 and the breakpoint of the translocation in cell line GM2324 at 22q12.2. LIF derives its name from its ability to induce the terminal differentiation of myeloid leukemic cells, thus preventing their continued growth. Other properties attributed to the cytokine include: the growth promotion and cell differentiation of different types of target cells, influence on bone metabolism, cachexia, neural development, embryogenesis and inflammation.;Species reactivity: Mouse;Application: ELISA;Assay info: ;Sensitivity: <10pg/ml |
 (OKEH04045)) LIF ELISA Kit (Mouse) (OKEH04045) |
|
OKEH04045 |
Aviva Systems Biology |
96 Wells |
EUR 652.8 |
|
Description: Description of target: LIF has the capacity to induce terminal differentiation in leukemic cells. Its activities include the induction of hematopoietic differentiation in normal and myeloid leukemia cells, the induction of neuronal cell differentiation, and the stimulation of acute-phase protein synthesis in hepatocytes.;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.039 ng/mL |
 LIF, Mouse Recombinant , 10MIU/ml |
|
L4501-001 |
GenDepot |
1ml |
EUR 1100 |
 Purified recombinant Mouse LIF protein |
|
MBS5308803-001mg |
MyBiosource |
0.01mg |
EUR 550 |
Purified recombinant Mouse LIF protein |
|
MBS5308803-5x001mg |
MyBiosource |
5x0.01mg |
EUR 2435 |
 Mouse LIF HEK293 Overexpression Lysate |
|
MBS8119752-03mg |
MyBiosource |
0.3mg |
EUR 280 |
Mouse LIF HEK293 Overexpression Lysate |
|
MBS8119752-5x03mg |
MyBiosource |
5x0.3mg |
EUR 1205 |
Mouse LIF HEK293 Overexpression Lysate |
|
MBS8119753-03mg |
MyBiosource |
0.3mg |
EUR 280 |
Mouse LIF HEK293 Overexpression Lysate |
|
MBS8119753-5x03mg |
MyBiosource |
5x0.3mg |
EUR 1205 |
) LIFR, Recombinant, Mouse (Leukemia Inhibitory Factor Receptor, LIF Receptor, LIF-R, D-factor/LIF Receptor, CD118) |
|
MBS636029-005mg |
MyBiosource |
0.05mg |
EUR 800 |
LIFR, Recombinant, Mouse (Leukemia Inhibitory Factor Receptor, LIF Receptor, LIF-R, D-factor/LIF Receptor, CD118) |
|
MBS636029-5x005mg |
MyBiosource |
5x0.05mg |
EUR 3455 |
 Mouse LIF Recombinant Protein Lyophilized |
|
IMSLIFRLY5UG |
Innovative research |
each |
EUR 317 |
|
|
|
Description: Mouse LIF Recombinant Protein Lyophilized |
Mouse LIF Recombinant Protein Lyophilized |
|
MBS8434242-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
 Human CellExp? LIF, mouse recombinant |
|
7268-10 |
Biovision |
each |
EUR 444 |
, Mouse) Leukemia Inhibitory Factor (LIF), Mouse |
|
MBS555550-0005mg |
MyBiosource |
0.005mg |
EUR 500 |
Leukemia Inhibitory Factor (LIF), Mouse |
|
MBS555550-001mg |
MyBiosource |
0.01mg |
EUR 670 |
Leukemia Inhibitory Factor (LIF), Mouse |
|
MBS555550-5x001mg |
MyBiosource |
5x0.01mg |
EUR 2855 |
, mouse) Leukemia Inhibitory Factor (LIF), mouse |
|
PR16102 |
Neuromics |
5 ug |
EUR 310.5 |
Leukemia Inhibitory Factor (LIF), mouse |
|
PR16102-B |
Neuromics |
each |
EUR 436.5 |
 Mouse LIF protein, C-His tag |
|
MBS9719051-0005mg |
MyBiosource |
0.005mg |
EUR 115 |
Mouse LIF protein, C-His tag |
|
MBS9719051-002mg |
MyBiosource |
0.02mg |
EUR 165 |
Mouse LIF protein, C-His tag |
|
MBS9719051-01mg |
MyBiosource |
0.1mg |
EUR 295 |
Mouse LIF protein, C-His tag |
|
MBS9719051-1mg |
MyBiosource |
1mg |
EUR 1680 |
Mouse LIF protein, C-His tag |
|
MBS9719051-5x1mg |
MyBiosource |
5x1mg |
EUR 7520 |
Mouse LIF protein, C-His tag |
|
PRP1126-100ug |
Abbkine |
100 μg |
EUR 379 |
|
Description: Mouse LIF protein, C-His tag, expressed in E. coli |
Mouse LIF protein, C-His tag |
|
PRP1126-1mg |
Abbkine |
1 mg |
EUR 2509 |
|
Description: Mouse LIF protein, C-His tag, expressed in E. coli |
Mouse LIF protein, C-His tag |
|
PRP1126-20ug |
Abbkine |
20 μg |
EUR 149 |
|
Description: Mouse LIF protein, C-His tag, expressed in E. coli |
Mouse LIF protein, C-His tag |
|
PRP1126-5ug |
Abbkine |
5 μg |
EUR 59 |
|
Description: Mouse LIF protein, C-His tag, expressed in E. coli |
 Mouse LIF ELISA Kit PicoKine® |
|
EK0580 |
BosterBio |
96 wells |
EUR 499 |
|
|
|
Description: Mouse LIF ELISA Kit PicoKine® (96 Tests). Quantitate Mouse Lif in cell culture supernatants, serum and plasma (heparin, EDTA). Sensitivity: 10pg/ml. |
 - Mouse leukemia inhibitory factor (Lif), transcript variant 1, (10ug)) Lif (untagged) - Mouse leukemia inhibitory factor (Lif), transcript variant 1, (10ug) |
|
MC208887 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 - Mouse leukemia inhibitory factor (Lif), transcript variant 2, (10ug)) Lif (untagged) - Mouse leukemia inhibitory factor (Lif), transcript variant 2, (10ug) |
|
MC208888 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 Recombinant Mouse Lif Protein, No Tag |
|
E40MOP2217 |
EnoGene |
20ug |
EUR 495 |
Recombinant Mouse Lif Protein, No Tag |
|
MOP2217 |
KMD Bioscience |
-
Ask for price
-
Ask for price
|
|
 Anti-Human LIF Antibody |
|
101-M553 |
ReliaTech |
100 µg |
EUR 399 |
|
Description: Based on its helical structure, LIF (Leukemia Inhibitory Factor) is considered a member of the Interleukin-6 family of cytokines. Functionally, it has been implicated in a many physiological processes including development, hematopoiesis, bone metabolism, and inflammation. Some cell types known to express LIF include activated T cells, monocytes, astrocytes, osteoblasts, keratinocytes, regenerating skeletal muscle, mast cells, and fibroblasts. |
Anti-Human LIF Antibody |
|
102-PA05S |
ReliaTech |
100 µg |
EUR 126 |
|
Description: Leukemia Inhibitory Factor also called LIF is a lymphoid factor that promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Leukemia Inhibitory Factor has several functions such as cholinergic neuron differentiation, control of stem cell pluripotency, bone & fat metabolism, mitogenesis of factor dependent cell lines & promotion of megakaryocyte production in vivo. Human and mouse LIF exhibit a 78% identity in its amino acid sequence. Human LIF is as active on human cells as is it is on mouse cells, though mouse LIF is about 1000 fold less active on human cells, than human LIF. |
Comparisons point out a excessive degree of settlement in responses throughout the protocols and tradition circumstances. The total correlation in outcomes was 0.88 between the usual and small quantity protocols, and 0.86 between the usual and capillary blood protocols. Repeatability for the small quantity and capillary blood protocols was excessive, with imply coefficient of variation throughout 5 replicates of 6.2 and 5.4%, respectively.ConclusionsThese outcomes reveal the feasibility of culturing cells and quantifying the inflammatory response to problem outdoors the lab, with a wide selection of potential functions in biobehavioral analysis in community-based and distant subject settings.
